Skip to main content
Explore URMC

Patrick M. Reagan, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Cancer, Hospital Medicine


I am a clinician and researcher specializing in the care of patients with both Non Hodgkin and Hodgkin lymphomas. Areas of particular interest include aggressive B-cell lymphomas, autologous stem cell transplantation and cellular therapy including chimeric antigen receptor (CAR) T-cells.

Lymphomas are a complex group of diseases and require a multidisciplinary team to manage. We are fortunate to have an excellent team at the Wilmot Cancer Institute including hematology and oncology, radiation oncology, hematopathology, dermatology, neurology, nursing, advanced practice providers, social work and members of the clinical trials office.

I am actively engaged in clinical trials research and feel that this is an important component of care for lymphoma patients.

Professional Background

Dr. Reagan is an Associate Professor of Medicine at the Wilmot Cancer Institute.

Dr. Reagan received his medical degree from Upstate Medical University in Syracuse, NY. He completed his internship and residency at the University of Virginia. He then served as a chief resident at the University of Virginia. He completed his fellowship in hematology at the Wilmot Cancer Institute at the University of Rochester Medical Center.

He started his faculty appointment at the Wilmot Cancer Institute in July 2015.



MD | SUNY Upstate College of Health Professions

Post-doctoral Training & Residency

07/01/2013 - 06/30/2015
Fellowship in Hematology & Oncology at University of Rochester Medical Center

07/01/2012 - 07/01/2013
Residency in Internal Medicine at University of Virginia-Radiology GME

07/01/2010 - 07/01/2012
Residency in Internal Medicine at University of Virginia-Radiology GME

07/01/2009 - 07/01/2010
Internship in Internal Medicine at University of Virginia-Radiology GME

VIEW ALL expand_more


Wilmot Cancer Institute Inspiration Award Immune Effector Cell Therapy Team

Lymphoma Research Foundation Clinical Research Mentoring Program

American Society of Hematology Clinical Research Training Institute

John and Carol Bennett Travel Fellowship Award
Sponsor: John and Carol Bennett
Location: Wilmot Cancer Institute

Alpha Omega Alpha, Upstate Medical University
Sponsor: Upstate Medical University

Phi Beta Kappa, St. Lawrence University
Sponsor: St. Lawrence University

Academic All American, Football, St. Lawrence University
Sponsor: St. Lawrence University

Beta Beta Beta, Biological Honor Society, St. Lawrence University
Sponsor: St. Lawrence University

VIEW ALL expand_more


Journal Articles

Roschewski M, Patel MR, Reagan PM, Saba NS, Collins GP, Arkenau HT, de Vos S, Nuttall B, Acar M, Burke K, White RD, Udriste M, Sharma S, Dougherty B, Stetson D, Jenkins D, Mortlock A, Forcina A, Munugalavadla V, Flinn I. "Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2023 Jun 26; Epub 2023 Jun 26.

Wallace DS, Rowland C, Hill BT, Baran AM, Casulo C, Reagan PM, Winter A, Karmali R, Winter JN, Gordon LI, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Ma S, Barr PM. "Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma." Leukemia & lymphoma.. 2023 Jun 21; :1-4. Epub 2023 Jun 21.

Westin JR, Oluwole OO, Kersten MJ, Miklos DB, Perales MA, Ghobadi A, Rapoport AP, Sureda A, Jacobson CA, Farooq U, van Meerten T, Ulrickson M, Elsawy M, Leslie LA, Chaganti S, Dickinson M, Dorritie K, Reagan PM, McGuirk J, Song KW, Riedell PA, Minnema MC, Yang Y, Vardhanabhuti S, Filosto S, Cheng P, Shahani SA, Schupp M, To C, Locke FL, . "Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma." The New England journal of medicine.. 2023 Jun 5; Epub 2023 Jun 05.